Then, we analyzed microarray data of 1809 patients with breast cancer, and found that high IL-17B expression was significantly correlated with poorer prognosis in the whole population and in the basal-like subtype, but not in other breast cancer subtypes. The gene discussed is IL17B; the disease is breast cancer.